Concourse Financial Group Securities, Inc. Renalytix PLC Put Options Transaction History
Concourse Financial Group Securities, Inc.
- $1.56 Billion
- Q2 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding RNLX
# of Institutions
29Shares Held
3.72MCall Options Held
0Put Options Held
0-
Pinnacle Associates LTD815KShares$146,7760.0% of portfolio
-
Stifel Financial Corp St. Louis, MO561KShares$100,9800.0% of portfolio
-
Levin Capital Strategies, L.P. New York, NY555KShares$99,9000.01% of portfolio
-
Tejara Capital LTD London, X0500KShares$90,0700.04% of portfolio
-
Ci Private Wealth, LLC Miami, FL336KShares$60,3920.0% of portfolio
About Renalytix plc
- Ticker RNLX
- Exchange OTC
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 37,445,900
- Market Cap $6.74M
- Description
- Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for kidney diseases. The company offers KidneyIntelX, a diagnostic platform that employs an artificial intelligence-enabled algorithm that combines various data inputs, including validated blood-based biomarkers, inherited genetics and personalized patient data ...